Clinical trial
Treatment of Diarrhea-predominant Irritable Bowel Syndrome With LACTEOL® 340 mg: A Pilot Study Evaluating Safety and Efficacy
NCT01358708 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Diarrhea-predominant Irritable Bowel Syndrome With LACTEOL® 340 mg: A Pilot Study Evaluating Safety and Efficacy
- Lead sponsor
- Forest Laboratories
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 30, 2010
- Completion date
- September 30, 2011
- Enrollment
- 26 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
diarrhea-predominant irritable bowel syndrome